prenatal diagnosis Flashcards

1
Q

basic principles of prenatal screening

A
  1. Screen the General Population for Common Disorders - Down syndrome, birth defects. 2. Offer Screening to at Risk Groups for Clustered Disorders- Cystic fibrosis, Tay Sachs. 3. Offer Screening to Families with Known Disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications for Ultrasound

A

Fetal presentation, Suspected multiple gestation, Establish EDD, Suspected fetal death, Suspected oligohydraminos, Abnormal AFP , fetal anatomy, placenta location
Fetal presentation, Suspected multiple gestation, Establish EDD, Suspected fetal death, Suspected oligohydraminos, Abnormal AFP , fetal anatomy, placenta location

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is gestational age estimated in first trimester

A

Crown-rump length on US- can only be used early because later on the fetus extends and flexes its spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is gestational age estimated in 2-3 trimester

A

Biparietal diameter, abdominal circumference, femur length on US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

screening for trisomies and neural tube defects

A

Check maternal serum for alpha-feto protein, unconjugated estriol, HcG and inhibin A. On US look for nuchal translucency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

list the non-invasive vs invasive testing methods

A

non invasive: maternal serum for analytes (ie. AFP), karyotype, fetal cells. Also ultrasound. Invasive: amniocentesis or chorionic villus sampling, both have small risk to fetus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

indications for invasive diagnostic methods

A

Advanced maternal age (defined as > 35 years old at due date), Positive aneuploidy screening test (biochemical and/or ultrasound), Abnormal ultrasound findings: anatomic, IUGR, amniotic fluid volume, Known parental chromosome rearrangements, Previous affected child

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is alpha feto protein made

A

fetal yolk sac and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is alpha feto protein

A

major blood protein of fetus- like albumin. It is not present in maternal blood normally, so any AFP is from the fetus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of high and low alpha feto protein

A

high: neural tube defects (the defect causes release of more AFP into the amniotic fluid), omphalocele (abd defect), gastroschisis (abd defect). Low: downs syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

list conditions which Ashkenazi Jews are at increased risk for

A

AR conditions- Tay Sachs, Canavan disease, Gaucher disease, Nieman-Pick disease, Bloom syndrome, Fanconi anemia C, and mucolipidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Tay Sachs

A

AR lysosomal storage disorder caused by a deficiency in hexosaminidase A. Gangliosides accumulate in the body, and their presence in the CNS leads to blindness, severe neurologic disease, and death, usually by the age of 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnosis of fetal Tay Sachs

A

Molecular DNA testing detects 94 % of heterozygotes, while the analysis of the ratio of hexosaminidase A to total hexosaminidase detects 98 %. In at risk pregnancies, fetal DNA can be evaluated from samples obtained via amniocentesis or CVS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diagnosis of hemoglobinopathies

A

Thalassemias: MCV <80% followed by hemoglobin electrophoresis once iron deficiency is excluded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cystic fibrosis diagnosis

A

Prenatally or newborn. Prenatal testing of CF gene . 75% have delta F508 deletion. Panels are available to test for less common mutations, but not all mutations are known so some may be missed. Start by testing mom, then offer partner testig if mom is positive. If both are affected, CVS or amniocentesis is offered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Screening for down sydrome

A

analyzes maternal blood: low AFP, increased hCG, low estriol, increased inhibin A, decreased PAPP-A. Levels of analytes are reported as multiples of the median values for fetuses of same gestational age. The ultrasound imaging component of the integrated screen includes a measurement of fetal nuchal thickness or translucency, due to increased fluid around neck.

17
Q

screening for trisomy 18

A

Maternal serum: low AFP, low unconjugated estriol, low hCG, decreased PAPP-A. Inhibin A not used. Nuchal translucency on US

18
Q

screening for trisomy 13

A

decreased PAPP-A in maternal serum

19
Q

screening for neural tube defect

A

maternal serum: increased AFP. Amniocentesis: increased AFP and acetylcholinesterase

20
Q

Circulating Cell Free Fetal DNA & Intact Fetal Cells

A

small amounts of cell free DNA from the fetus can be detected in maternal blood- currently being used to look at chromosomes 13, 18, 21, X and Y. Massively parallel sequencing compares the levels of cell free chromosomes compared to a normal range.

21
Q

amniocentesis

A

needle used to collect amniotic fluid and fetal cells. Can be done btw 14-20 weeks, using US guidance

22
Q

Chorionic Villus Sampling

A

A catheter is passed into the placenta under ultrasound guidance. Trophoblast cells from the chorionic villi are obtained. CVS can be safely performed from 9.5 -12.5 weeks gestation. Does not detect neural tube defects

23
Q

Percutaeous umbilical cord blood sampling

A

involves introducing a needle into the umbilical cord near its site of insertion into the placenta and extracting fetal blood. Highly invasive, the complication rate is 1 to 2%, and is largely dependent on the associated fetal status. This is usually reserved for assessing fetal anemia and diagnosing fetal infections in severely compromised fetuses.

24
Q

pre-implantation genetic diagnosis during IVF

A

polar body biopsy, blastomere biopsy or aspiration from the six- to eight-cell embryo at 2 to 3 days, and trophectoderm biopsy from the 5- to 6-day blastocyst. Blastomere biopsy on day 3 is the most common technique